Recent News View all news Apr 29, 2024 Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B Read more » Apr 25, 2024 Labcorp Announces 2024 First Quarter Results Read more » Apr 24, 2024 Labcorp Announces Winning Bid for Select Assets of Invitae Read more » Apr 15, 2024 Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw Read more » Events View all events Apr 25, 2024 at 9:00 AM EDT Q1 2024 Laboratory Corporation of America Holdings Earnings Conference Call Click Here for Webcast Feb 15, 2024 at 9:00 AM EST Q4 and Full Year 2023 Laboratory Corporation of America Holdings Earnings Conference Call Click Here for Webcast Jan 9, 2024 at 4:30 PM PST Laboratory Corporation of America Holdings at the 42nd Annual J.P. Morgan Healthcare Conference Click Here for Webcast Financial Documents Current and historical annual reports and proxy statements View Documents SEC Filings View Labcorp’s annual filings, current reports and historic filings View Reports Corporate Governance Corporate management, board of directors and committee overview Learn moreabout corporate governance News & Events Press releases, news and events for investors News and Events Stock & Fundamentals Labcorp trading statistics, balance sheets, cash flow and income statements Fundamentals Contacts Investor Relations contact information Contact Information